Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
429 studies found for:    vinblastine
Show Display Options
Rank Status Study
1 Completed Study of Vinblastine and Sirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors Including Central Nervous System Tumors
Conditions: Solid Tumors;   Central Nervous System Tumors
Intervention: Drug: Vinblastine and Sirolimus
2 Active, not recruiting Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs)
Condition: Glioma
Intervention: Drug: Vinblastine Sulphate
3 Completed Phase 2 Study of Vinblastine in Children With Recurrent or Refractory Low Grade Glioma
Condition: Glioma
Intervention: Drug: vinblastine sulphate injection
4 Recruiting Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults
Conditions: Refractory Low-grade Gliomas;   Recurrent Low-grade Gliomas
Interventions: Drug: Vinblastine + Nilotinib;   Drug: Vinblastine
5 Recruiting Vinblastine/Prednisone Versus Single Therapy With Cytarabine for Langerhans Cell Histiocytosis (LCH)
Condition: Langerhans Cell Histiocytosis
Interventions: Drug: Cytarabine;   Drug: Vinblastine/prednisone
6 Completed Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
Conditions: Brain and Central Nervous System Tumors;   Neurofibromatosis Type 1
Interventions: Drug: carboplatin;   Drug: vinblastine sulfate
7 Recruiting Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG)
Condition: Low Grade Glioma
Interventions: Drug: Vinblastine;   Drug: Bevacizumab
8 Active, not recruiting Vinblastine and Temsirolimus in Pediatric Patients With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours
Conditions: Recurrent Lymphoma;   Refractory Lymphoma;   Solid Tumours;   Central Nervous System
Interventions: Drug: Vinblastine;   Drug: Temsirolimus
9 Recruiting Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults
Conditions: Refractory Low-grade Gliomas;   Recurrent Low-grade Gliomas
Interventions: Drug: Nilotinib;   Drug: Vinblastine
10 Completed Vinblastine and Methotrexate in Children With Pulmonary Vein Stenosis
Condition: Intraluminal Pulmonary Vein Stenosis
Interventions: Drug: Vinblastine;   Drug: Methotrexate
11 Completed Vinblastine and Methotrexate in Treating Children With Desmoid Tumors
Condition: Desmoid Tumor
Interventions: Drug: methotrexate;   Drug: vinblastine sulfate
12 Completed
Has Results
Genetic Variates of Response to Cisplatin, Vinblastine, and Temozolomide (CVT) in Patients With Metastatic Melanoma
Conditions: Melanoma;   Skin Cancer
Intervention: Drug: Cisplatin, Vinblastine, Temozolomide
13 Completed Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas
Conditions: Neurofibromatosis Type 1;   Precancerous Condition
Interventions: Drug: Methotrexate;   Drug: Vinblastine
14 Recruiting Bendamustine Study in Classical Hodgkin Lymphoma Patients Over 60 Treated by Prednisone, Vinblastine and Doxorubicin
Condition: Classical Hodgkin Lymphoma
Interventions: Drug: Bendamustine;   Drug: Prednisone;   Drug: Vinblastine;   Drug: Doxorubicin
15 Completed Gamma-secretase/Notch Signalling Pathway Inhibitor RO4929097 in Combination With Cisplatin, Vinblastine, and Temozolomide in Treating Patients With Recurrent or Metastatic Melanoma
Conditions: Recurrent Melanoma;   Stage IV Skin Melanoma
Interventions: Drug: Cisplatin;   Drug: Gamma-Secretase Inhibitor RO4929097;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study;   Drug: Temozolomide;   Drug: Vinblastine Sulfate
16 Not yet recruiting A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma
Condition: Hodgkin Disease
Interventions: Drug: Brentuximab vedotin;   Drug: Doxorubicin;   Drug: Vinblastine;   Drug: Dacarbazine
17 Terminated
Has Results
Metronomic Therapy in Patients With Metastatic Melanoma
Condition: Metastatic Melanoma
Interventions: Drug: vinblastine;   Drug: Cyclophosphamide;   Drug: dacarbazine
18 Completed A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer
Conditions: Kidney Neoplasms;   Neoplasm Metastasis
Interventions: Drug: PSC 833;   Drug: vinblastine
19 Not yet recruiting Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer
Condition: Carcinoma, Non-Small-Cell Lung
Interventions: Drug: Paclitaxel;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Vinblastine Sulfate;   Radiation: three dimensional conformal radiotherapy
20 Completed
Has Results
Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma
Condition: Lymphoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: mercaptopurine;   Drug: methotrexate;   Drug: prednisone;   Drug: vinblastine sulfate;   Drug: vincristine sulfate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.